Effect of Occupational Therapy at Home E-Rehabilitation (OTHER) for Persons Post-stroke

Sponsor
Amsterdam University of Applied Sciences (Other)
Overall Status
Recruiting
CT.gov ID
NCT05855226
Collaborator
ZonMw: The Netherlands Organisation for Health Research and Development (Other), Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (Other)
180
7
2
21.4
25.7
1.2

Study Details

Study Description

Brief Summary

The goal of this (cost)effectiveness study is to compare care as usual with OTHER-intervention in Cerebro Vascular Accident (CVA) older adults in Geriatric

Rehabilitation (GR). The main question[s] it aims to answer are:
  1. What is the effectiveness of OTHER, as compared to occupational therapy as usual (CAU), on improving the self-perceived performance in daily activities of community-dwelling older persons post-stroke over a 24-week period after initiation of OTHER or CAU, as measured longitudinally (at week 4, 13 and 26)?
Secondary:
  1. What is the effectiveness of OTHER on improving satisfaction with the perceived daily performance of community-dwelling persons post-stroke, 26 weeks after start compared to usual OT? (quantitative approach)

  2. What is the effectiveness of OTHER on improving physical activity of community-dwelling persons post-stroke, 26 weeks after start compared to usual OT? (quantitative approach)

  3. What is the effectiveness of OTHER on improving self-management of community-dwelling persons post-stroke, 26 weeks after start compared to usual OT? (quantitative approach)

  4. How do persons post-stroke and OT's experience and how do they reflect on OTHER in supporting a sense of self-management, safety and improving daily functioning? (qualitative approach).

  5. What factors influenced the intervention delivery and the perceived benefits in the OTHER study (process evaluation)? 1) monitoring treatment fidelity, barriers and facilitators for implementation; 2) gain insight into the impact of OTHER on the GR transition to home; 3) to gain insight into what stroke survivors and OT's think of OTHER. 4) how participants, and professionals experience and thoughts they have on the OTHER-intervention in supporting daily functioning and self-management

Cost-effectiveness

  1. What is the cost-effectiveness of OTHER on improving self-perceived performance in daily activities and Quality Adjusted Life Years (QALYs) of community-dwelling persons post-stroke, 26 weeks after start compared to usual OT? (quantitative approach)

Participants will get the OTHER-intervention treatment given by de occupational therapist which consists of activity monitoring, coaching and videoconferencing to optimalise the transition from clinical care to home.

Researchers will compare care as usual to see if there is a effect on improving the self-perceived performance in daily activities, self-management and improving physical activity .

Condition or Disease Intervention/Treatment Phase
  • Other: OTHER-intervention (Occupational Therapy at Home E-Rehabilitation)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
180 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Supporting Daily Functioning of Persons With a Neurological Disorder: (Cost)Effectiveness of Occupational Therapy at Home E-Rehabilitation (OTHER) for Persons Post-stroke
Anticipated Study Start Date :
May 20, 2023
Anticipated Primary Completion Date :
Mar 1, 2025
Anticipated Study Completion Date :
Mar 1, 2025

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Care as usual

Care as usual, consist of GR rehabilitation when a patient is back at home.

Experimental: OTHER-intervention

The OTHER-intervention is part of the OT care. Start during inpatient GR rehabilitation and goes on 12 weeks afte discharge when a patient is home. The OT will coach a patient and use a activity monitoring system. Also videoconferencing will be used.

Other: OTHER-intervention (Occupational Therapy at Home E-Rehabilitation)
The occupational therapist will use activity monitoring and coaching techniques with videoconference during OTHER.

Outcome Measures

Primary Outcome Measures

  1. Changes in Canadian Occupational Performance measure (COPM-p) at three time points [The investigators assess the changes across three time points (one, three and six months)]

    The primary outcome measure is 'perceived daily performance' 4 weeks, 12 weeks and 24 weeks after the start of OTHER compared to baseline functioning, measured with the Canadian Occupational Performance measure. The COPM results in a performance score (COPM-p). The COPM is a person-centred, occupation-focused outcome measure for the detection of change in perceived daily performance over time. The COPM results in a performance score (COPM-p) and a satisfaction score (COPM-s). Through a semi-structured interview, persons will prioritize up to five daily activities that deemed most important and rate each on a 10-point scale regarding perceived performance (COPM-p) (1=not able to do at all and 10 = able to do extremely well. The mean COPM-p will be obtained by summing the ratings and dividing them by the number of prioritized activities.

Secondary Outcome Measures

  1. Changes in Canadian Occupational Performance measure (COPM-s) [baseline, 4 weeks after discharge GR, 12 weeks after discharge GR and 24 weeks after discharge GR]

    Persons post-stroke satisfaction in performing daily functioning will be measured with the COPM-s(35). Next to the COPM-p, participants rated the prioritized daily activities on a 10-point scale regarding performance satisfaction (COPM-s) (1= not satisfied at all and 10= extremely satisfied).

  2. Self-management [baseline, 4 weeks after discharge GR, 12 weeks after discharge GR and 24 weeks after discharge GR]

    Self-management. The Patient-Reported Outcome Occupational Therapy (PROM-OT) is developed to measure the outcome and quality of OT in the Netherlands from a client perspective.The PROM-OT contains 13 questions regarding the outcome of OT for the person (e.g. I can perform my daily activities, whether or not with help/devices (for example self-care, household, leisure, work) and using scoring with 11 point scale (0= lowest score and 10 = highest score). It focusses on daily activities, being able to self-manage related to daily functioning and satisfaction of OT.

  3. Patient's quality of life. [baseline,4 weeks after discharge GR, 12 weeks after discharge GR and 24 weeks after discharge GR]

    The EuroQol-5D-5L(41) will be used to measure 'health-related quality of life' outcomes (HRQOL).The HRQOL is measured on 5 health dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each health dimension has 5 severity levels ranging between no problems to extreme problems. The EQ- visual analogue scale (VAS) measures the persons' self-rated health on a scale from 0 to 100 (0= worst health and 100 the best health). The participants' EQ-5D-5L health states will be converted into utility values the Dutch tariff.

  4. Capability of older people [baseline,4 weeks after discharge GR, 12 weeks after discharge GR and 24 weeks after discharge GR]

    The ICEpop CAPability measure for Older people (ICECAP-O) is a measure of capability in older people for use in economic evaluation. Unlike most profile measures used in economic evaluations, the ICECAP-O focuses on wellbeing defined in a broader sense, rather than health. The measure covers attributes of wellbeing that were found to be important to older people in the United Kingdom. ICECAP-O comprises five attributes (the lay terms are in brackets): Attachment (love and friendship), Security (thinking about the future without concern), Role (doing things that make participants feel valued), Enjoyment (enjoyment and pleasure), Control (independence). Score from 1 till 4 (1 = lowest and 4 = highest score

  5. Activity level [up to 15 weeks]

    The wearable activity monitor (PAM) will be applied to measure the amount of active movement in minutes per day.

  6. Mobility functioning [baseline and 24 weeks after discharge GR]

    Time up and go test is a screening tool used to test basic mobility skills of frail elderly patients (60-90 years old) an persons with stroke.

  7. Satisfaction with OT [baseline, 4 weeks after discharge GR, 12 weeks after discharge GR and 24 weeks after discharge GR]

    The Patient-Reported Outcome Measure - Occupational Therapy (PROM-OT) is developed to measure the outcome and quality of OT in the Netherlands from a client perspective. The PROM-OT contains 13 questions regarding the outcome of OT for the person (e.g. I can perform my daily activities, whether or not with help/devices (for example self-care, household, leisure, work) and using scoring with 11 point scale (0= lowest score and 10 = highest score). It focusses on daily activities, being able to self-manage related to daily functioning and satisfaction of OT.

  8. Societal cost [12 weeks after discharge GR and 24 weeks after discharge GR]

    Costs will be measured from a societal perspective, meaning that all costs related to the intervention will be measured, irrespective of who pays or benefits from them. Cost will be measured using retrospective cost questionnaires administered after 12 weeks and 24 weeks.

Other Outcome Measures

  1. Sociodemographic characteristics [baseline]

    age, gender, date and time of admission hospital or geriatric clinic, date of discharge, the highest level of education, marital status, and living arrangement (minimal Data Set)

  2. Chronic conditions [baseline and 24 weeks after discharge GR]

    will be measured by the Functional Comorbidity Index (FCI). The FCI is a sum of 18 self-reported comorbid conditions with a score of 0 to 18. A score of 0 indicating no comorbid illness and a score of 18 indicating the highest number of comorbid illnesses. Comorbidities assessed by the index include arthritis, hypertension, asthma, hearing impairment, visual impairment, gastrointestinal disease, chronic obstructive pulmonary disease/emphysema, osteoporosis, angina, anaemia, congestive heart failure or heart disease, heart attack, neurological disease, stroke/transient ischemic attack, peripheral vascular disease, diabetes mellitus (type I or II), depression, degenerative disc disease and obesity.

  3. Cognitive functioning [baseline and 24 weeks after discharge GR]

    To classify the severity of cognitive impairment the Montreal Cognitive Assessment (MoCA) will be used. The MoCA is a 30-point test administered in 10 minutes. The MoCA assesses orientation, short-term memory, visuospatial abilities, attention/concentration, language, and aspects of executive functioning. Data on its psychometric properties are limited, but preliminary results suggest that it has good test-retest reliability (+/- 1 point) and internal consistency (0.83). During the feasibility study the investigators experienced participants with light cognitive impairments and the OTHER-intervention was very useful. De score off 16 is based on de feasibility study and literature. The cutoff point for MoCA is a critical point and debated in literature. MoCA uses the cutoff of 26 is inadequate for the stroke setting. Normality range from 19 till 22 in acute stroke phase.

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • be able to walk a few steps with or without a walking device.

  • 60 years or older

  • an assessment score of at least 16 on the Montreal Cognitive Assessment (MoCA)

  • an indication for follow up GR at home

Exclusion Criteria:
  • Who are terminally ill

  • Who have severe aphasia; problems with understanding.

  • Who has been assessed legally incapable by a geriatric doctor

Contacts and Locations

Locations

Site City State Country Postal Code
1 TanteLouise Bergen Op Zoom Brabant Netherlands 4613 AK
2 ZZG Herstelcentrum Groesbeek Gerlderland Netherlands 6561 LE
3 Cicero Zorggroep Brunssum Limburg Netherlands 6441 CR
4 Sevagram Heerlen Limburg Netherlands 6419 PB
5 Zorgcirkel Westerhout Alkmaar Noord-holland Netherlands 1814 DE
6 Omring locatie Lindendeal Hoorn Noord-holland Netherlands 1624 AB
7 Vivium Naardenheem Naarden Noord-Holland Netherlands 1411 HB

Sponsors and Collaborators

  • Amsterdam University of Applied Sciences
  • ZonMw: The Netherlands Organisation for Health Research and Development
  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Investigators

  • Study Director: Margo van Hartingsveldt, Dr., Amsterdam University of Applied Sciences

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sanne Pellegrom, MSc. of Health Science - Principal Investigator, Amsterdam University of Applied Sciences
ClinicalTrials.gov Identifier:
NCT05855226
Other Study ID Numbers:
  • 80-86900-98-022
First Posted:
May 11, 2023
Last Update Posted:
May 11, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 11, 2023